HBIO
NASDAQ · Life Sciences Tools & Services
Harvard Bioscience Inc
$9.52
+0.31 (+3.31%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+275.5% upside
Low Target
$24.20
Average Target
$35.75
High Target
$46.73
Current Price
$9.52
Current
$9.52
$9.52
Target
$35.75
$35.75
$24.20
$35.75 avg
$46.73
Scenario Analysis
Bear Case
$24.20
154.2%
Low target
Base Case
$35.75
+275.5%
Avg target
Bull Case
$46.73
+390.9%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.10
4.6% from high
52-Week Low
$4.00
+138.0% from low
Target vs 52W High
$35.75
+292.9% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 79% | $369.21 | -46.8% |
| DHR | Strong Buy | 31 | 84% | $158.11 | -31.3% |
| A | Buy | 30 | 73% | $64.69 | -62.6% |
| IQV | Strong Buy | 26 | 92% | $82.96 | -69.4% |
| WAT | Strong Buy | 28 | 75% | $189.60 | -59.0% |
| MTD | Hold | 19 | 47% | $170.43 | -90.2% |
| ILMN | Hold | 28 | 54% | $169.36 | -19.2% |
| WST | Strong Buy | 21 | 95% | $136.24 | -66.9% |